| Literature DB >> 30236530 |
Robert K Flamm1, Paul R Rhomberg2, Amy A Watters2, Kim Sweeney3, Evelyn J Ellis-Grosse3, Dee Shortridge2.
Abstract
Fosfomycin and comparators were susceptibility tested against over 2200 contemporary clinical isolates from US medical centers. Fosfomycin was active against Enterobacterales (MIC50/90, 4/16 μg/mL), including multidrug-resistant isolates. Potent activity was exhibited against gram-positive organisms, including Staphylococcus aureus (MIC50/90, 4/8 μg/mL). Fosfomycin may provide a promising alternative option for treatment of infections where resistant bacteria may occur.Entities:
Keywords: Enterobacterales; Fosfomycin; SENTRY
Mesh：
Substances：
Year: 2018 PMID： 30236530 DOI： 10.1016/j.diagmicrobio.2018.08.010
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN： 0732-8893 Impact factor: 2.803